Timothy Hlavinka
Urology · San Antonio, TXNPI 1982684098
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,033 and has fallen 88.3% since, to $121 in 2025. That places this record below the midpoint for urology clinicians in TX, where the typical reported total is $3,394.
Across 117 payments — averaging $24.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$401
- Myovant Sciences Inc.$276
- Procept Biorobotics Corporation$274
- Astellas Pharma US Inc$221
- Johnson & Johnson$205
- Pfizer$188
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,852100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $401 |
| Myovant Sciences Inc. | 13 | $276 |
| Procept Biorobotics Corporation | 3 | $274 |
| Astellas Pharma US Inc | 12 | $221 |
| Johnson & Johnson | 11 | $205 |
| Pfizer | 12 | $188 |
| Antares Pharma, Inc. | 8 | $136 |
| Profound Medical Corp. | 1 | $135 |
| Bayer | 5 | $94 |
| Urovant Sciences Inc | 4 | $84 |
| Dendreon Pharmaceuticals LLC | 3 | $80 |
| Urogen Pharma, Inc. | 3 | $58 |
| Endo Pharmaceuticals Inc. | 3 | $53 |
| Myriad Genetic Laboratories, Inc. | 1 | $52 |
| Travere Therapeutics, Inc. | 3 | $51 |
| Amgen | 3 | $46 |
| Acerus Pharmaceuticals Corporation | 3 | $46 |
| Tolmar Pharmaceuticals, Inc. | 2 | $42 |
| Merck | 2 | $41 |
| AbbVie | 2 | $37 |
| Bluewind Medical | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Tolmar, Inc. | 1 | $27 |
| Blue Earth Diagnostics | 1 | $25 |
| AstraZeneca | 1 | $24 |
| 180 Medical, Inc. | 1 | $23 |
| RGH Enterprises LLC | 1 | $21 |
| Neotract Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Ambu Inc. | 1 | $16 |
| Cook Medical LLC | 1 | $16 |
| Baudax Bio Inc. | 1 | $15 |
| Levita Magnetics International Corp | 1 | $15 |
| Novo Nordisk | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,863 in reported general payments places this provider in the 40th percentile of 878 urology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Silodosin | 27 | $2,524 |
| Dutasteride | 24 | $1,040 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $277 |
| Tamsulosin Hcl | 18 | $187 |
| Fluconazole | 14 | $150 |
| Levofloxacin | 17 | $150 |
| Anastrozole | 13 | $91 |
Paid to pharmacies, not to this prescriber.
Other urology in San Antonio
- Daniel SaltzsteinSan Antonio$547K
- Leroy JonesSan Antonio$506K
- Jose de la CerdaSan Antonio$278K
- Naveen KellaSan Antonio$84K
- Christopher CantrillSan Antonio$73K
- Robert SvatekSan Antonio$51K
- Andrew von EschenbachMontgomery$3.2M
- Brian MazzarellaLakeway$1.2M
- Arun RaiHouston$920K
- Allen MoreyDallas$914K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.